The Venture Codex Logo

The Venture Codex

Mission BioCapital

139 Main Street Suite 401, Cambridge, MA, 02142, United States

Overview

Venture capital firm investing in early-stage life science companies.

Founded

2009

Deals ยท 12mo

6

Links

WebsiteLinkedInX (Twitter)

Stage focus

Series A
Series B

Geographic focus

United States

Sector focus

Life Science
Medical
Venture Capital

Investment portfolio

43rounds
NAMEDATESIZE
Breye Therapeutics
Sep 2026Led
$77 MSeries A
Cloverleaf Bio
Sep 2026Participated
$33 MSeed
Enodia Therapeutics
Jan 2026Participated
$24 MSeed
EpiBiologics
Jan 2026Participated
$107 MSeries B
Nocion Therapeutics
Jan 2026Participated
$23 MSeries B
AI Proteins
Nov 2025Led
$42 MSeries A
Sensorium Therapeutics
Aug 2025Participated
$25 MSeries A
SiteOne Therapeutics
Dec 2024Participated
$100 MSeries C
Alessa Therapeutics
Dec 2024Led
$15 MSeed
Nuvig Therapeutics
Dec 2024Participated
$161 MSeries B
Integrated Biosciences
Oct 2024Participated
$17 MSeed
ImmunOs Therapeutics
Sep 2024Led
$11 MSeries C
Breye Therapeutics
Sep 2026Led
$77 MSeries A
Cloverleaf Bio
Sep 2026Participated
$33 MSeed
Enodia Therapeutics
Jan 2026Participated
$24 MSeed
EpiBiologics
Jan 2026Participated
$107 MSeries B
Nocion Therapeutics
Jan 2026Participated
$23 MSeries B
AI Proteins
Nov 2025Led
$42 MSeries A
Sensorium Therapeutics
Aug 2025Participated
$25 MSeries A
SiteOne Therapeutics
Dec 2024Participated
$100 MSeries C
Alessa Therapeutics
Dec 2024Led
$15 MSeed
Nuvig Therapeutics
Dec 2024Participated
$161 MSeries B
Integrated Biosciences
Oct 2024Participated
$17 MSeed
ImmunOs Therapeutics
Sep 2024Led
$11 MSeries C
43
Items
...
Browse all public portfolio deals

Insights

Time horizon

View by

Deal Distribution

Mission BioCapital: 43 funding rounds are recorded in the selected participation categories.All available history.
Mission BioCapital: 43 funding rounds are recorded in the selected participation categories. All available history
Round typeLed dealsParticipated deals
Seed15
Series A613
Series B014
Series C+11
Other Equity11

Monthly Deal Activity

Mission BioCapital: 43 deals are recorded across 115 months.All available history.
Mission BioCapital: 43 deals are recorded across 115 months. All available history
MonthDeals
Apr '171
May '170
Jun '170
Jul '170
Aug '170
Sep '170
Oct '170
Nov '170
Dec '170
Jan '181
Feb '180
Mar '180
Apr '181
May '180
Jun '180
Jul '181
Aug '180
Sep '180
Oct '180
Nov '181
Dec '180
Jan '190
Feb '190
Mar '190
Apr '191
May '190
Jun '192
Jul '190
Aug '190
Sep '190
Oct '190
Nov '191
Dec '190
Jan '200
Feb '200
Mar '200
Apr '201
May '201
Jun '200
Jul '200
Aug '200
Sep '201
Oct '201
Nov '200
Dec '200
Jan '210
Feb '210
Mar '210
Apr '210
May '211
Jun '211
Jul '211
Aug '210
Sep '211
Oct '211
Nov '210
Dec '211
Jan '221
Feb '221
Mar '220
Apr '220
May '221
Jun '222
Jul '220
Aug '220
Sep '220
Oct '220
Nov '221
Dec '220
Jan '231
Feb '230
Mar '232
Apr '230
May '230
Jun '230
Jul '230
Aug '230
Sep '230
Oct '230
Nov '230
Dec '230
Jan '240
Feb '240
Mar '241
Apr '240
May '242
Jun '240
Jul '240
Aug '240
Sep '241
Oct '241
Nov '240
Dec '243
Jan '250
Feb '250
Mar '250
Apr '250
May '250
Jun '250
Jul '250
Aug '251
Sep '250
Oct '250
Nov '251
Dec '250
Jan '263
Feb '260
Mar '260
Apr '260
May '260
Jun '260
Jul '260
Aug '260
Sep '262
Oct '260

Sector Breakdown

Mission BioCapital: Health & Life Sciences is the largest displayed sector by deal count (43 deals).All available history.

A deal can appear in multiple sectors, so sector totals may overlap. Capital represents disclosed total round sizes, not fund cheque sizes.

Mission BioCapital: Health & Life Sciences is the largest displayed sector by deal count (43 deals). All available history
SectorDeals
Health & Life Sciences43
AI & Machine Learning3
Space & Frontier Tech2
Manufacturing1
Consumer & Lifestyle1

Deal Size Distribution

Mission BioCapital: 43 rounds have a disclosed size in the displayed size bands.All available history.

Undisclosed round sizes are excluded. Capital represents total round sizes, not fund cheque sizes.

Mission BioCapital: 43 rounds have a disclosed size in the displayed size bands. All available history
Round size band (USD)Deals
<$5M2
$5M-$10M2
$10M-$25M10
$25M-$50M10
$50M-$100M14
$100M-$250M5
$250M-$500M0
$500M-$1B0
$1B+0

Deals By Geography

Mission BioCapital: United States has the largest recorded deal count among the displayed regions (39 deals).All available history.

Top 2 of 2 regions; European countries are grouped as Europe.

Mission BioCapital: United States has the largest recorded deal count among the displayed regions (39 deals). All available history
RegionDeals
United States39
Europe4
Mission BioCapital: 20 co-investors are shown, with Pfizer Ventures sharing 6 recorded deals.All available history.

Co-Investors

Bubble size = shared deals

Click a bubble to open that fund in a new tab.

Shows up to 20 co-investors ranked by shared deals. Deals may be shared with multiple funds, so rows overlap. Capital is total round size, not fund cheque size.

Mission BioCapital: 20 co-investors are shown, with Pfizer Ventures sharing 6 recorded deals. All available history
Co-investorShared deals
Pfizer Ventures6
RA Capital Management6
Novo Holdings5
Alexandria Venture Investments4
Canaan Partners4
Dolby Family Ventures4
INKEF Capital4
SR One4
Amgen Ventures3
Atlas Venture3
Bristol Myers Squibb3
Digitalis Ventures3
Droia Ventures3
Eli Lilly and Company3
F-Prime Capital3
Gimv3
Mass General Brigham Ventures3
MP Healthcare Venture Management3
Polaris Partners3
Samsara BioCapital3

Investment Strategy

Mission BioCapital: Led accounts for 21% and participating for 79% of round participation.All available history.
Mission BioCapital: Led accounts for 21% and participating for 79% of round participation. All available history
CategoryDeals (count)Share (%)
Led921%
Participating3479%
Mission BioCapital: Single-lead accounts for 22% and co-led for 78% of lead dynamics.All available history.
Mission BioCapital: Single-lead accounts for 22% and co-led for 78% of lead dynamics. All available history
CategoryDeals (count)Share (%)
Single-lead222%
Co-led778%

Team

Douglas Crawford

Managing Partner

Eric Linsley

Managing General Partner

Johannes Fruehauf

General Partner and Co-Founder

Peter Parker

Managing General Partner

Steven Tregay

Founder

Zach Collins

Partner